Trial intelligence / Profile preview

Sertraline in Total Hip Arthroplasty

IRCT20200305046700N4Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of sertraline in hip osteoarthritis, sponsored by Tehran University of Medical Sciences. Started Aug 2024; status: completed.

02

Drugs

sertraline
03

Conditions

hip osteoarthritis

Beyond the preview

Go deeper on IRCT20200305046700N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200305046700N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call